Monomethyl fumarate
- Generic Name
- Monomethyl fumarate
- Brand Names
- Bafiertam
- Drug Type
- Small Molecule
- Chemical Formula
- C5H6O4
- CAS Number
- 2756-87-8
- Unique Ingredient Identifier
- 45IUB1PX8R
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients
- Conditions
- Interventions
- First Posted Date
- 2012-03-06
- Last Posted Date
- 2019-05-31
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 106
- Registration Number
- NCT01544491
- Locations
- 🇬🇧
Novartis Investigative Site, Nottingham, United Kingdom
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
- First Posted Date
- 2011-09-19
- Last Posted Date
- 2017-09-27
- Target Recruit Count
- 19
- Registration Number
- NCT01436305
- Locations
- 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸University of California San Francisco, San Francisco, California, United States
Research Study of ATG and Rituximab in Renal Transplantation
- Conditions
- Interventions
- First Posted Date
- 2011-03-21
- Last Posted Date
- 2018-11-29
- Target Recruit Count
- 10
- Registration Number
- NCT01318915
- Locations
- 🇺🇸
University of California San Francisco Medical Center, San Francisco, California, United States
🇺🇸University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸Rogosin Institute/New York Presbyterian-Cornell, New York, New York, United States
A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients
- First Posted Date
- 2009-12-17
- Last Posted Date
- 2015-08-27
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 23
- Registration Number
- NCT01033864
Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2019-02-01
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 139
- Registration Number
- NCT00928018
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection
- Conditions
- Interventions
- First Posted Date
- 2009-04-22
- Last Posted Date
- 2014-09-18
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 240
- Registration Number
- NCT00885820
A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.
- Conditions
- Interventions
- First Posted Date
- 2008-07-22
- Last Posted Date
- 2009-09-15
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 48
- Registration Number
- NCT00720408
A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients
- Conditions
- Interventions
- First Posted Date
- 2008-07-17
- Last Posted Date
- 2015-12-17
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 73
- Registration Number
- NCT00717678
Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2009-02-17
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 400
- Registration Number
- NCT00611494
- Locations
- 🇨🇦
Toronto General Hospital - Multi Organ Transplant Program, Toronto, Ontario, Canada
MMF After Pediatric Liver Transplantation
- Conditions
- First Posted Date
- 2006-08-22
- Last Posted Date
- 2011-05-20
- Lead Sponsor
- Hannover Medical School
- Target Recruit Count
- 25
- Registration Number
- NCT00367146
- Locations
- 🇩🇪
Hannover medical School, Hannover, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.